0
Arcturus Therapeutics Holdings Inc. Banner Image

Arcturus Therapeutics Holdings Inc. has reached its limit for free report views

Work for Arcturus Therapeutics Holdings Inc.? Upgrade Your Profile and unlock all your annual reports.

Arcturus Therapeutics Holdings Inc.

  • Ticker ARCT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arcturus Therapeutics Holdings Inc. Logo Image
  • 51-200 Employees
  • Based in San Diego, California
Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR™ mRNA Technology and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus’ diverse pipeline of RNA therapeutic and vaccine candidatesMore includes self-replicating mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to potentially treat Ornithine Transcarbamylase (OTC) Deficiency, Cystic Fibrosis, Cardiovascular Disease along with partnered programs including Glycogen Storage Disease Type 3, Hepatitis B Virus, and non-alcoholic steatohepatitis (NASH). Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, DNA, and gene editing therapeutics. Arcturus’ technologies are covered by its extensive patent portfolio (192 patents and patent applications, issued in the U.S., Europe, Japan, China and other countries). Arcturus’ commitment to the development of novel RNA therapeutics has led to collaborations with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, CureVac AG, Synthetic Genomics Inc., Duke-NUS, and the Cystic Fibrosis Foundation.
Arcturus Therapeutics Holdings Inc.

Most Recent Annual Report

Arcturus Therapeutics Holdings Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Arcturus Therapeutics Holdings Inc. has reached its limit for free report views.

Older/Archived Annual Reports